3 studies referred to GSH but did not give data, 5 studies were conference abstracts we were unable to gain access to this data, despite three attempts at email correspondence with the authors
Similar proportions of males and females achieved the body weight reduction thresholds of at least 5%, 10%, and 15% with tirzepatide treatment in SURMOUNT-1, -2, and -4, or achieved the 15% target in SURMOUNT-3
1 As of 2025, roughly 10 million Americans 2 are on GLP-1s, for both treatment of type 2 diabetes and weight loss, and that number is expected to reach 25 million by 2030
If youre still determining whether semaglutide is appropriate for you, the free assessment quiz is the easiest way to start the process
Theres no generic Saxenda version yet
Diabetes 64 , 819827 (2015)